Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Viewray Inc (VRAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 848,339
  • Shares Outstanding, K 96,953
  • Annual Sales, $ 80,960 K
  • Annual Income, $ -76,400 K
  • 60-Month Beta 0.82
  • Price/Sales 10.62
  • Price/Cash Flow N/A
  • Price/Book 6.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.24
  • Number of Estimates 5
  • High Estimate -0.18
  • Low Estimate -0.26
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.14 +8.35%
on 06/03/19
9.04 -2.43%
on 05/30/19
+0.19 (+2.20%)
since 05/17/19
3-Month
6.56 +34.45%
on 05/02/19
9.04 -2.43%
on 05/30/19
+0.65 (+7.96%)
since 03/15/19
52-Week
4.86 +81.48%
on 12/24/18
13.21 -33.23%
on 07/25/18
+1.36 (+18.23%)
since 06/15/18

Most Recent Stories

More News
World's First MRIdian Center Treats 1,000th Patient with MRI-Guided Radiation Therapy

ViewRay, Inc. (Nasdaq: VRAY) announced today that the clinical team at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has treated its 1,000th...

VRAY : 8.79 (+0.46%)
ViewRay® to Present at the Jefferies 2019 Global Healthcare Conference

ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in the Jefferies 2019 Global Healthcare Conference in New York, New York. Scott Drake, President and CEO, will participate...

VRAY : 8.79 (+0.46%)
Biotech Stocks: Global Revenues for Ophthalmology Market Projected to Reach $26 Billion by 2022

As the baby boomer generation ages, there is an increased need no a demand by these aging patients to avert vision and blindness problems that come with aging. An industry report GBI Research stated that...

PTCT : 40.05 (+0.10%)
GHSI : 1.60 (unch)
RMTI : 4.28 (+2.39%)
BSGM : 8.20 (+3.67%)
VRAY : 8.79 (+0.46%)
Biotech Stocks - U.S. Holds On With Largest Medical Device Market Estimated at over $150 Billion

Medical device and technology development is an area where the U.S. companies are at the forefront. According to a SelectUSA.gov publication, the United States remains the largest medical device market...

CELG : 97.44 (+0.96%)
MHMNF : 54.5000 (unch)
IMGN : 2.02 (+2.02%)
VRAY : 8.79 (+0.46%)
ALXN : 122.05 (+3.49%)
ViewRay (VRAY) Reports Q1 Loss, Lags Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of -54.55% and -3.30%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

VRAY : 8.79 (+0.46%)
ViewRay Reports First Quarter 2019 Results

ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2019.

VRAY : 8.79 (+0.46%)
ViewRay's MRIdian to be Featured at Leading European Radiation Oncology Meeting

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the European Society for Radiotherapy and Oncology...

VRAY : 8.79 (+0.46%)
Global Cellulite Treatments Market Could Exceed $1.4 Billion by 2026

The global cellulite market and its largest segment, the non-invasive treatment sector, are both expected to grow at a healthy rate. A recent industry report on the entire cellulite market (from Transparency...

HSM.TO : 3.77 (-2.84%)
CTLT : 50.49 (+1.61%)
HSDT : 2.81 (-3.77%)
VRAY : 8.79 (+0.46%)
MDT : 97.20 (-0.31%)
SOLY : 16.50 (+15.38%)
ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company has partnered with Minogue Medical Inc., a leading Canadian distributor of surgical devices, operating room disposables, hospital equipment,...

VRAY : 8.79 (+0.46%)
ViewRay Partners with Largest Independent Distributor in Australia and New Zealand to Bring Benefits of MRI-Guided Radiation Therapy to the Region

ViewRay, Inc. (Nasdaq: VRAY) and Device Technologies Australia Pty Ltd (Device Technologies) announced today a partnership in which Device Technologies, the largest independent distributor in Australasia,...

VRAY : 8.79 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade VRAY with:

Business Summary

ViewRay Inc. is a medical device company. The company develops advanced radiation therapy technology for the treatment of cancer. MRIdian system provides continuous soft-tissue imaging during treatment. ViewRay Inc. is headquartered in Oakwood Village, Ohio.

See More

Key Turning Points

2nd Resistance Point 9.01
1st Resistance Point 8.88
Last Price 8.79
1st Support Level 8.67
2nd Support Level 8.59

See More

52-Week High 13.21
Fibonacci 61.8% 10.02
Fibonacci 50% 9.03
Last Price 8.79
Fibonacci 38.2% 8.05
52-Week Low 4.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar